Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review

Renal cell carcinoma (RCC) associated with anaplastic lymphoma kinase (ALK) gene rearrangements (ALK-RCC) is currently considered an “emerging or provisional” tumor entity by the last World Health Organization classification published in 2016. Although several studies assessing ALK-RCC’s clinical an...

Descripción completa

Detalles Bibliográficos
Autores principales: Iannantuono, Giovanni Maria, Riondino, Silvia, Sganga, Stefano, Roselli, Mario, Torino, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999731/
https://www.ncbi.nlm.nih.gov/pubmed/35409355
http://dx.doi.org/10.3390/ijms23073995

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999731/
https://www.ncbi.nlm.nih.gov/pubmed/35409355
http://dx.doi.org/10.3390/ijms23073995

Ejemplares similares